Atlas of Genetics and Cytogenetics in Oncology and Haematology

Home   Genes   Leukemias   Solid Tumors   Cancer-Prone   Deep Insight   Case Reports   Journals  Portal   Teaching   

X Y 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 NA

MCM3 (minichromosome maintenance complex component 3)

Written2014-10Kaifee Arman, Esra Bozgeyik, Yusuf Ziya Igci
University of Gaziantep, Faculty of Medicine, Department of Medical Biology, Gaziantep, Turkey

Abstract Review on MCM3, with data on DNA/RNA, on the protein encoded and where the gene is implicated.

(Note : for Links provided by Atlas : click)


Alias (NCBI)HCC5
HGNC (Hugo) MCM3
HGNC Previous nameminichromosome maintenance deficient (S. cerevisiae) 3
 MCM3 minichromosome maintenance deficient 3 (S. cerevisiae)
LocusID (NCBI) 4172
Atlas_Id 41319
Location 6p12.2  [Link to chromosome band 6p12]
Location_base_pair Starts at 52264015 and ends at 52284742 bp from pter ( according to GRCh38/hg38-Dec_2013)  [Mapping MCM3.png]
Fusion genes
(updated 2017)
Data from Atlas, Mitelman, Cosmic Fusion, Fusion Cancer, TCGA fusion databases with official HUGO symbols (see references in chromosomal bands)
ATP8B4 (15q21.2)::MCM3 (6p12.2)CALR (19p13.2)::MCM3 (6p12.2)MCM3 (6p12.2)::CARS (11p15.4)
MCM3 (6p12.2)::FOXP4 (6p21.1)SLC11A2 (12q13.12)::MCM3 (6p12.2)


  Figure 1. MCM3 gene location, the representation of two major splice variants, and the depiction of major motifs.
Description The human MCM3 gene is located on the minus strand and spans 20868 bps of genomic region (52264014-52284881). This gene has 7 transcripts (splice variants). It has 853 amino acids and its size is about 91 kDa. It contains a nuclear localization signal and possess an ATPase/helicase region at the centre. It has a total of 17 exons and extends a bit more than 20 KB of genomic DNA. (Hofmann et al., 2000) (Fig. 1).
Transcription There are two transcript variants encoding different isoforms known for MCM3. These are transcript variant 1 (accession number NM_002388.4) and transcript variant 2 (NM_001270472.1). The transcript variant 2 lacks an alternate exon compared to transcript variant 1. MCM3 gene has been observed to be expressed highly in different cancer cell lines as compared to normal tissues (Ha et al., 2004). Higher mRNA expression of MCM3 was also shown to be linked with papillary thyroid carcinoma (PTC) (Igci et al., 2014). The expression level of MCM3 is also increased in cell lines overexpressing E2F, suggesting that MCM3 is also target of E2F (Leone et al., 1998; Bruemmer et al., 2003).
Pseudogene There is no known pseudogene for MCM3.


Description The protein encoded by MCM3 gene is known to be a well conserved mini-chromosome maintenance protein (MCM) which is needed for triggering the eukaryotic genome replication. It acts as DNA replication licensing factor. The well known other synonym for this protein is DNA polymerase alpha holoenzyme-associated protein P1 due to its indispensable role in DNA replication and cell proliferation and also participates in the control of genome duplication during cell cycle. The MCM3 protein is composed of 808 amino acid residues, having molecular mass of approximately 91 kDa and a basal isoelectric point of 5.53.The MCM3 protein is subunit of the protein complex (MCM 2-7) i.e the minichromosome maintenance (MCM) complex. It contains active ATPase sites which supplement to the helicase activity needed during DNA replication. MCM3 protein contains 8 nucleotide length region that binds nucleotide phosphates. (Fig. 2).
MCM3AP (Minichromosome Maintenance-3 Associated Protein) interacts and acetylates MCM3 protein inhibiting cell cycle progression. There is an interaction between MCM3 and MCM3AP which is required for nuclear localization and chromatin binding of MCM3AP (Takei et al., 2002). The acetylase activity of MCM3AP is known to inhibit only initiation of DNA replication and does not inhibit its elongation (Takei et al., 2002). MCM3 are known to have distinguishable nuclear localization sequences (NLS), indicating that these MCMs help in providing nuclear targeting to different other members of the MCM family (Kimura et al., 1996; Forsburg, 2004).
Like other MCM proteins, MCM3 is a member of the AAA+ class of ATPases. It contains binding site for ATP, Walker A motif, Walker B motif and arginine motif. AAA+ ATPases usually form ATP-dependent complexes usually heterohexamers. The structure of MCM3 includes the MCM box spanning about 200 residues. This peculiar MCM box has two ATPase consensus domains or motifs. One of them is the Walker A domain which includes the active site with P-loop. In Walker A consensus, glycine is replaced by alanine or serine along with many other conserved residues, eventually forming the MCM-specific region GDPxx(S/A)KS (Forsburg, 2004). Other is the classic Walker B which is hydrophobic in nature that is primarily responsible for the hydrolysis of ATP rather than binding. Like all the MCM proteins, the Walker B motif of MCM3 possess the conserved sequence IDEFDKM that distinguishes the MCM family. There is also presence of a short motif, SRFD that is present about 70 residues following the Walker B element, constitutes an "arginine finger". Infact all other MCMs also contain these sequences.
The MCM3 also possesses a zinc finger residing prior to the MCM box that somewhat matches a classic zinc finger region, but has been stated that the residues are capable of chelating zinc (Fletcher et al., 2003). Biochemical analysis also revealed that the zinc motif aids in formation of complex assembly as well as ATPase activity (Poplawski et al., 2001; Fletcher et al., 2003). Members of the AAA+ ATPases are well known to function as molecular chaperons. The AAA+ proteins possess several distinct characteristics. The formation of active ATPase sites in the MCM2-7 ring takes place via interacting surfaces of two adjacent subunits. This interaction occurs in such a way that the conserved arginine finger motif resides in trans relative to the Walker A box (ATP-binding site) of the of the adjacent subunit.
  Figure 2. MCM3 protein sequence showing AAA region (blue coloured), ATP binding site (blue colour underlined), Walker A motif (highlighted with yellow color), Walker B motif (highlighted with grey color), SRFD arginine finger motif (red).
Expression Despite an increase in transcription for some MCM genes during the G1/S phase in dividing cells, MCM3 protein levels remain constant during the cell cycle (Forsburg et al., 1997; Diffley and Labib, 2002). MCM3 protein is found to have nuclear expression in all in proliferating cells. There is high expression of MCM3 proteins in trophoblastic cells of placenta, hematopoietic cells of bone marrow. But it has not been detected in decidual cells of placenta, brain, liver, kidney, ovary, spleen, lung, skeletal muscles, smooth muscles and heart muscles. This DNA replication licensing factor is also expressed at lower intensity in many other cell types, including squamous epithelial cells of oesophagus, glandular cells of appendix and breast, urothelial cells of the urinary bladder, respiratory epithelial cells of nasopharynx.
Localisation The MCM3 protein is localized to the nucleus.
Function MCM3 protein is extremely conserved mini-chromosome maintenance proteins (MCM) in eukaryotes and is ubiquitously expressed. MCM3 is one of the members of MCM family with chromatin-binding proteins. MCM3 by acting as an indispensable factor permits a single round of replication of DNA per cell cycle. It is responsible for the initiation of eukaryotic genome replication and cell proliferation and monitors the cell cycle control of genome duplication. MCM3 gene encodes P1 protein which has a role in the DNA replication process.
MCM3 protein is part of the protein complex consisting of MCM2-7. It participates in the formation of the heterohexameric MCM complex, which is loaded onto the chromatin at sites of DNA replication, leading to the formation of pre-replication complex (pre-RC). The proteins that compose the MCM complex also serve as DNA helicases that unwind the DNA double helix at the replication forks apart from the initiation of replication. Furthermore, MCM3 actively participates in cell cycle regulation. The MCM3 is responsible for genome stability, as it limits the replication to only once per cell cycle.
MCMs have a direct role in transcription. There are several evidences suggesting that the MCM proteins do associate with specific transcription factors. Mcm3-Mcm5 complex forms a heterodimer associating with STAT1a (a transcription factor) during biochemical purification (Zhang et al., 1998; DaFonseca et al., 2001). Infact MCM5 mediates this association. MCM3, MCM2 and MCM5 form the peripheral subunits of the complex that is known to negatively regulate the active MCM core subunits (MCM4, MCM6 and MCM7). It is known to interact directly with MCM5/CDC46. The well known MCM3 acetylating protein, MCM3AP (a chromatin-associated acetyltransferase) binds and acetylates MCM3 further inhibiting the initiation of DNA replication including cell cycle progression.
It has been shown that there is a functional interaction between two important moieties i.e the glucocorticoid receptor and GANP (germinal center-associated protein)/MCM3AP. GANP and MCM3AP are known to bind to the MCM3 protein which is involved in triggering of DNA replication (Osman et al., 2006). It is shown that cyclin E/Cdk2 phosphorylates MCM3 at a particular site i.e Thr722, regulating the loading of MCM3 onto chromatin and thus controls S phase checkpoint (Li et al., 2011). Mcm3, Mcm2 and Mcm4 show cell cycle specific phosphorylation that relates to chromatin binding. They are shown to be hypophosphorylated and chromatin-bound in G1 which eventually gets phosphorylated by Cdk activity at G1/S and later in the cell cycle (Fujita et al., 1998). Phosphorylation of Mcm proteins is also needed for pre-RC assembly and activation which is dependent on Cdk activity and Cdc7-Dbf4 kinase is also required (Sato et al., 1997; Weinreich and Stillman, 1999; Masai et al., 2000). In summary, the molecular function of MCM3 includes DNA helicase activity, DNA binding, protein binding and ATP binding while the biological processes of MCM3 includes DNA replication initiation, DNA strand elongation, mitotic cell cycle, DNA replication, DNA duplex unwinding, G1/S transition during mitotic cell cycle.
Homology The gene encoding the human P1 protein (MCM3) has 60% homology to the yeast MCM3 (minichromosome maintenance deficiency) replication control gene of S. cerevisiae (Thommes et al., 1992). In another study it has been observed that MCM3 shares three central regions of high sequence similarity i.e about 75% as well as highly hydrophilic carboxy-terminal region with the Mcm3 replication protein of the yeast (Schulte et al., 1995). MCM3 is also homologous to other MCM complex components (MCM2, MCM5, MCM6, MCM7) and can form several kind of heteromeric complexes. Mutants defective in MCM2 or MCM3 are extremely similar in phenotype. They both possess an autonomously replicating sequence (ARS)-specific minichromosome maintenance defect, however their ARS specificities are not identical. MCM3 resembles MCM2 as they both contain NLS (Nuclear localization sequences) and are involved in translocating the complex from the cytoplasm to the nucleus (Gozuacik et al., 2003).


Note A nuclear localization signal of human MCM3 has been clarified and being established that mutagenesis on the nuclear localization signal of MCM3 affects the binding of newly isolated MCM3-assosiated protein, Map80 (Takei and Tsujimoto, 1998). In Saccharomyces cerevisiae, two mutant alleles i.e mcm3-1 and mcm3-10 that are defective at different steps of the replication initiation process have been characterized (Lei et al., 2002). Both Mcm3-10 and Mcm3-1 have defectiveness with regard to the recruitment of the MCM2-7 complex to replication origins. Mcm3-10 affects a step before, and Mcm3-1 affects a step after the recruitment of the MCM2-7 complex to replication origins. Mcm3-1 has a G246E mutation that lessens the efficiency of replication initiation (Yan et al., 1993).

Implicated in

Entity Uterine cervical cancer
Note It has been shown that MCM3 is ubiquitously expressed in cancer cells by immunohistochemical studies of surgical materials from human uterine. Moreover, cancerous cells has higher MCM3 expression than in normal proliferating cells of the uterine cervix and dysplastic cells, making it a useful marker to differentiate these cells (Ishimi et al., 2003). These results indicate that the malignant transformation of cells is directly related to the higher expression of MCM3 protein.
Entity Papillary thyroid carcinoma
Note Papillary thyroid carcinoma (PTC) is known to be the most common histological type among the other types which accounts for up to 80 % of the total thyroid cancer cases (Fagin and Mitsiades, 2008). It has been shown that the MCM3 protein expression levels were overexpressed in papillary thyroid as compared to normal thyroid tissues through immunohistochemical analysis and Western blot analysis (Lee et al., 2010). A comparative study of MCM3 protein expression levels was also done in follicular variant of papillary thyroid carcinoma (FVPTC), classic variant of papillary thyroid carcinoma (CVPTC), and multi-nodular goitre (MNG) tissues. MCM3 protein expression was higher in FVPTC and CVPTC as compared to MNG (Igci et al., 2011; Igci et al., 2014). This shows that MCM3 might be used as a suitable marker in order to distinguish FVPTC and CVPTC from MNG.
Entity Brain malignancies
Note MCM3 shows a restricted immune response by cancer in patients with brain malignancies. It is a strong predictor of survival in patients with anaplastic astrocytoma (Soling et al., 2005). MCM3 has been shown to have higher expression in human astrocytic tumors and highlights a cancer-restricted humoral immune response in patients with brain tumors and brain metastases but not in healthy controls. MCM3 expression in diffuse astrocytoma is found to be significantly associated with age, histologic grade, time to recurrence (Soling et al., 2005).
Entity Endometrial carcinogenesis
Note The expression of MCM3 in endometrial carcinomas was shown to be significantly lower than the normal proliferative endometrium. The expression of MCM3 also differs according to the phases. It is significantly higher in the proliferative phase than in the secretory phase. The above observations show that the expression of MCM3 reflects cell proliferation in normal and hyperplastic endometria (Kato et al., 2003). The replication-licensing system may be aberrant in endometrial carcinomas as there is an inconsistency between the expression of MCMs and cell proliferation in endometrial carcinomas.
Entity Salivary gland tumors
Note MCM3 was significantly higher in mucoepidermoid carcinomas (MEC) and adenoid cystic carcinomas (ADCC) with respect to pleomorphic adenomas (PA). A high sensitivity and specificity for MCM3 was obtained to differentiate benign and malignant tumors (Ashkavandi et al., 2013).
Entity Other malignancies
Note Minichromosome maintenance 3 (MCM3) gene was highly expressed in a lot of human cancers, like lymphoma, leukemia, carcinomas of the uterine cervix, stomach, breast, kidney and lung, malignant melanoma as well as benign and malignant melanocytic skin lesions (Ha et al., 2004; Gambichler et al., 2009). MCM3 protein was also found to be upraised in several human cancer tissues analysed by western blot and immunohistochemical analyses (Ha et al., 2004).

To be noted

Acknowledgments: Kaifee Arman is recipient of Graduate Scholarship from TUBITAK under the program 2215-Graduate Scholarship Program for International Students.


MCM3 as a novel diagnostic marker in benign and malignant salivary gland tumors.
Ashkavandi ZJ, Najvani AD, Tadbir AA, Pardis S, Ranjbar MA, Ashraf MJ.
Asian Pac J Cancer Prev. 2013;14(6):3479-82.
PMID 23886132
Rapamycin inhibits E2F-dependent expression of minichromosome maintenance proteins in vascular smooth muscle cells.
Bruemmer D, Yin F, Liu J, Kiyono T, Fleck E, Van Herle AJ, Law RE.
Biochem Biophys Res Commun. 2003 Mar 28;303(1):251-8.
PMID 12646195
Identification of two residues in MCM5 critical for the assembly of MCM complexes and Stat1-mediated transcription activation in response to IFN-gamma.
DaFonseca CJ, Shu F, Zhang JJ.
Proc Natl Acad Sci U S A. 2001 Mar 13;98(6):3034-9. Epub 2001 Mar 6.
PMID 11248027
The chromosome replication cycle.
Diffley JF, Labib K.
J Cell Sci. 2002 Mar 1;115(Pt 5):869-72. (REVIEW)
PMID 11870205
Molecular pathology of thyroid cancer: diagnostic and clinical implications.
Fagin JA, Mitsiades N.
Best Pract Res Clin Endocrinol Metab. 2008 Dec;22(6):955-69. doi: 10.1016/j.beem.2008.09.017. (REVIEW)
PMID 19041825
The structure and function of MCM from archaeal M. Thermoautotrophicum.
Fletcher RJ, Bishop BE, Leon RP, Sclafani RA, Ogata CM, Chen XS.
Nat Struct Biol. 2003 Mar;10(3):160-7.
PMID 12548282
Mutational analysis of Cdc19p, a Schizosaccharomyces pombe MCM protein.
Forsburg SL, Sherman DA, Ottilie S, Yasuda JR, Hodson JA.
Genetics. 1997 Nov;147(3):1025-41.
PMID 9383050
Eukaryotic MCM proteins: beyond replication initiation.
Forsburg SL.
Microbiol Mol Biol Rev. 2004 Mar;68(1):109-31. (REVIEW)
PMID 15007098
Cell cycle- and chromatin binding state-dependent phosphorylation of human MCM heterohexameric complexes. A role for cdc2 kinase.
Fujita M, Yamada C, Tsurumi T, Hanaoka F, Matsuzawa K, Inagaki M.
J Biol Chem. 1998 Jul 3;273(27):17095-101.
PMID 9642275
Minichromosome maintenance proteins are useful adjuncts to differentiate between benign and malignant melanocytic skin lesions.
Gambichler T, Shtern M, Rotterdam S, Bechara FG, Stucker M, Altmeyer P, Kreuter A.
J Am Acad Dermatol. 2009 May;60(5):808-13. doi: 10.1016/j.jaad.2009.01.028.
PMID 19389522
Identification and functional characterization of a new member of the human Mcm protein family: hMcm8.
Gozuacik D, Chami M, Lagorce D, Faivre J, Murakami Y, Poch O, Biermann E, Knippers R, Brechot C, Paterlini-Brechot P.
Nucleic Acids Res. 2003 Jan 15;31(2):570-9.
PMID 12527764
Cancer-associated expression of minichromosome maintenance 3 gene in several human cancers and its involvement in tumorigenesis.
Ha SA, Shin SM, Namkoong H, Lee H, Cho GW, Hur SY, Kim TE, Kim JW.
Clin Cancer Res. 2004 Dec 15;10(24):8386-95.
PMID 15623617
Genomic structure of the gene for the human P1 protein (MCM3) and its exclusion as a candidate for autosomal recessive polycystic kidney disease.
Hofmann Y, Becker J, Wright F, Avner ED, Mrug M, Guay-Woodford LM, Somlo S, Zerres K, Germino GG, Onuchic LF.
Eur J Hum Genet. 2000 Mar;8(3):163-6.
PMID 10780780
Differential expression of a set of genes in follicular and classic variants of papillary thyroid carcinoma.
Igci YZ, Arslan A, Akarsu E, Erkilic S, Igci M, Oztuzcu S, Cengiz B, Gogebakan B, Cakmak EA, Demiryurek AT.
Endocr Pathol. 2011 Jun;22(2):86-96. doi: 10.1007/s12022-011-9157-8.
PMID 21509594
MCM3 protein expression in follicular and classical variants of papillary thyroid carcinoma.
Igci YZ, Erkilic S, Igci M, Arslan A.
Pathol Oncol Res. 2014 Jan;20(1):87-91. doi: 10.1007/s12253-013-9662-9. Epub 2013 Jul 3.
PMID 23821456
Enhanced expression of Mcm proteins in cancer cells derived from uterine cervix.
Ishimi Y, Okayasu I, Kato C, Kwon HJ, Kimura H, Yamada K, Song SY.
Eur J Biochem. 2003 Mar;270(6):1089-101.
PMID 12631269
Expression of replication-licensing factors MCM2 and MCM3 in normal, hyperplastic, and carcinomatous endometrium: correlation with expression of Ki-67 and estrogen and progesterone receptors.
Kato K, Toki T, Shimizu M, Shiozawa T, Fujii S, Nikaido T, Konishi I.
Int J Gynecol Pathol. 2003 Oct;22(4):334-40.
PMID 14501812
Mouse MCM proteins: complex formation and transportation to the nucleus.
Kimura H, Ohtomo T, Yamaguchi M, Ishii A, Sugimoto K.
Genes Cells. 1996 Nov;1(11):977-93.
PMID 9077461
Minichromosome maintenance protein 3 is a candidate proliferation marker in papillary thyroid carcinoma.
Lee YS, Ha SA, Kim HJ, Shin SM, Kim HK, Kim S, Kang CS, Lee KY, Hong OK, Lee SH, Kwon HS, Cha BY, Kim JW.
Exp Mol Pathol. 2010 Feb;88(1):138-42. doi: 10.1016/j.yexmp.2009.09.015. Epub 2009 Oct 8.
PMID 19818763
Two mcm3 mutations affect different steps in the initiation of DNA replication.
Lei M, Cheng IH, Roberts LA, McAlear MA, Tye BK.
J Biol Chem. 2002 Aug 23;277(34):30824-31. Epub 2002 Jun 11.
PMID 12060653
E2F3 activity is regulated during the cell cycle and is required for the induction of S phase.
Leone G, DeGregori J, Yan Z, Jakoi L, Ishida S, Williams RS, Nevins JR.
Genes Dev. 1998 Jul 15;12(14):2120-30.
PMID 9679057
Phosphorylation of MCM3 protein by cyclin E/cyclin-dependent kinase 2 (Cdk2) regulates its function in cell cycle.
Li J, Deng M, Wei Q, Liu T, Tong X, Ye X.
J Biol Chem. 2011 Nov 18;286(46):39776-85. doi: 10.1074/jbc.M111.226464. Epub 2011 Sep 30.
PMID 21965652
Human Cdc7-related kinase complex. In vitro phosphorylation of MCM by concerted actions of Cdks and Cdc7 and that of a criticial threonine residue of Cdc7 bY Cdks.
Masai H, Matsui E, You Z, Ishimi Y, Tamai K, Arai K.
J Biol Chem. 2000 Sep 15;275(37):29042-52.
PMID 10846177
Functional interaction between the glucocorticoid receptor and GANP/MCM3AP.
Osman W, Laine S, Zilliacus J.
Biochem Biophys Res Commun. 2006 Oct 6;348(4):1239-44. Epub 2006 Aug 7.
PMID 16914116
The zinc finger domain of the archaeal minichromosome maintenance protein is required for helicase activity.
Poplawski A, Grabowski B, Long SE, Kelman Z.
J Biol Chem. 2001 Dec 28;276(52):49371-7. Epub 2001 Oct 17.
PMID 11606589
Human and Xenopus cDNAs encoding budding yeast Cdc7-related kinases: in vitro phosphorylation of MCM subunits by a putative human homologue of Cdc7.
Sato N, Arai K, Masai H.
EMBO J. 1997 Jul 16;16(14):4340-51.
PMID 9250678
Expression, phosphorylation and nuclear localization of the human P1 protein, a homologue of the yeast Mcm 3 replication protein.
Schulte D, Burkhart R, Musahl C, Hu B, Schlatterer C, Hameister H, Knippers R.
J Cell Sci. 1995 Apr;108 ( Pt 4):1381-9.
PMID 7615659
Minichromosome maintenance protein 3 elicits a cancer-restricted immune response in patients with brain malignancies and is a strong independent predictor of survival in patients with anaplastic astrocytoma.
Soling A, Sackewitz M, Volkmar M, Schaarschmidt D, Jacob R, Holzhausen HJ, Rainov NG.
Clin Cancer Res. 2005 Jan 1;11(1):249-58.
PMID 15671553
The MCM3 acetylase MCM3AP inhibits initiation, but not elongation, of DNA replication via interaction with MCM3.
Takei Y, Assenberg M, Tsujimoto G, Laskey R.
J Biol Chem. 2002 Nov 8;277(45):43121-5. Epub 2002 Sep 10.
PMID 12226073
Identification of a novel MCM3-associated protein that facilitates MCM3 nuclear localization.
Takei Y, Tsujimoto G.
J Biol Chem. 1998 Aug 28;273(35):22177-80.
PMID 9712829
Properties of the nuclear P1 protein, a mammalian homologue of the yeast Mcm3 replication protein.
Thommes P, Fett R, Schray B, Burkhart R, Barnes M, Kennedy C, Brown NC, Knippers R.
Nucleic Acids Res. 1992 Mar 11;20(5):1069-74.
PMID 1549468
Cdc7p-Dbf4p kinase binds to chromatin during S phase and is regulated by both the APC and the RAD53 checkpoint pathway.
Weinreich M, Stillman B.
EMBO J. 1999 Oct 1;18(19):5334-46.
PMID 10508166
Cell cycle-regulated nuclear localization of MCM2 and MCM3, which are required for the initiation of DNA synthesis at chromosomal replication origins in yeast.
Yan H, Merchant AM, Tye BK.
Genes Dev. 1993 Nov;7(11):2149-60.
PMID 8224843
Ser727-dependent recruitment of MCM5 by Stat1alpha in IFN-gamma-induced transcriptional activation.
Zhang JJ, Zhao Y, Chait BT, Lathem WW, Ritzi M, Knippers R, Darnell JE Jr.
EMBO J. 1998 Dec 1;17(23):6963-71.
PMID 9843502


This paper should be referenced as such :
Kaifee Arman, Esra Bozgeyik, Yusuf Ziya Igci
MCM3 (minichromosome maintenance complex component 3)
Atlas Genet Cytogenet Oncol Haematol. 2015;19(10):611-616.
Free journal version : [ pdf ]   [ DOI ]

External links


HGNC (Hugo)MCM3   6945
Entrez_Gene (NCBI)MCM3    minichromosome maintenance complex component 3
AliasesHCC5; P1-MCM3; P1.h; RLFB
GeneCards (Weizmann)MCM3
Ensembl hg19 (Hinxton)ENSG00000112118 [Gene_View]
Ensembl hg38 (Hinxton)ENSG00000112118 [Gene_View]  ENSG00000112118 [Sequence]  chr6:52264015-52284742 [Contig_View]  MCM3 [Vega]
ICGC DataPortalENSG00000112118
TCGA cBioPortalMCM3
AceView (NCBI)MCM3
Genatlas (Paris)MCM3
SOURCE (Princeton)MCM3
Genetics Home Reference (NIH)MCM3
Genomic and cartography
GoldenPath hg38 (UCSC)MCM3  -     chr6:52264015-52284742 -  6p12.2   [Description]    (hg38-Dec_2013)
GoldenPath hg19 (UCSC)MCM3  -     6p12.2   [Description]    (hg19-Feb_2009)
GoldenPathMCM3 - 6p12.2 [CytoView hg19]  MCM3 - 6p12.2 [CytoView hg38]
Genome Data Viewer NCBIMCM3 [Mapview hg19]  
Gene and transcription
Genbank (Entrez)AI683709 AK222586 AK299566 AK300754 AK301704
RefSeq transcript (Entrez)NM_001270472 NM_001366369 NM_001366370 NM_001366371 NM_001366372 NM_001366373 NM_001366374 NM_001366375 NM_002388
Consensus coding sequences : CCDS (NCBI)MCM3
Gene ExpressionMCM3 [ NCBI-GEO ]   MCM3 [ EBI - ARRAY_EXPRESS ]   MCM3 [ SEEK ]   MCM3 [ MEM ]
Gene Expression Viewer (FireBrowse)MCM3 [ Firebrowse - Broad ]
GenevisibleExpression of MCM3 in : [tissues]  [cell-lines]  [cancer]  [perturbations]  
BioGPS (Tissue expression)4172
GTEX Portal (Tissue expression)MCM3
Human Protein AtlasENSG00000112118-MCM3 [pathology]   [cell]   [tissue]
Protein : pattern, domain, 3D structure
UniProt/SwissProtP25205   [function]  [subcellular_location]  [family_and_domains]  [pathology_and_biotech]  [ptm_processing]  [expression]  [interaction]
NextProtP25205  [Sequence]  [Exons]  [Medical]  [Publications]
With graphics : InterProP25205
Catalytic activity : Enzyme3.6.4.12 [ Enzyme-Expasy ] [ IntEnz-EBI ] [ BRENDA ] [ KEGG ]   [ MEROPS ]
Domaine pattern : Prosite (Expaxy)MCM_1 (PS00847)    MCM_2 (PS50051)   
Domains : Interpro (EBI)AAA+_ATPase    MCM    Mcm3    MCM_CS    MCM_dom    MCM_lid    MCM_N    MCM_OB    NA-bd_OB-fold    P-loop_NTPase   
Domain families : Pfam (Sanger)MCM (PF00493)    MCM_lid (PF17855)    MCM_N (PF14551)    MCM_OB (PF17207)   
Domain families : Pfam (NCBI)pfam00493    pfam17855    pfam14551    pfam17207   
Domain families : Smart (EMBL)AAA (SM00382)  MCM (SM00350)  
Conserved Domain (NCBI)MCM3
PDB Europe6XTX    6XTY   
PDB (PDBSum)6XTX    6XTY   
PDB (IMB)6XTX    6XTY   
Structural Biology KnowledgeBase6XTX    6XTY   
SCOP (Structural Classification of Proteins)6XTX    6XTY   
CATH (Classification of proteins structures)6XTX    6XTY   
AlphaFold pdb e-kbP25205   
Human Protein Atlas [tissue]ENSG00000112118-MCM3 [tissue]
Protein Interaction databases
IntAct (EBI)P25205
Complex Portal (EBI)P25205 CPX-2940 MCM complex
Ontologies - Pathways
Ontology : AmiGOdouble-strand break repair via break-induced replication  chromosome, telomeric region  DNA binding  DNA helicase activity  DNA replication origin binding  single-stranded DNA binding  protein binding  ATP binding  nucleus  nucleus  nucleoplasm  nucleoplasm  alpha DNA polymerase:primase complex  nucleolus  centrosome  DNA replication  pre-replicative complex assembly involved in nuclear cell cycle DNA replication  DNA replication initiation  DNA strand elongation involved in DNA replication  membrane  hydrolase activity  DNA duplex unwinding  pre-replicative complex assembly  MCM complex  MCM complex  perinuclear region of cytoplasm  CMG complex  mitotic DNA replication initiation  
Ontology : EGO-EBIdouble-strand break repair via break-induced replication  chromosome, telomeric region  DNA binding  DNA helicase activity  DNA replication origin binding  single-stranded DNA binding  protein binding  ATP binding  nucleus  nucleus  nucleoplasm  nucleoplasm  alpha DNA polymerase:primase complex  nucleolus  centrosome  DNA replication  pre-replicative complex assembly involved in nuclear cell cycle DNA replication  DNA replication initiation  DNA strand elongation involved in DNA replication  membrane  hydrolase activity  DNA duplex unwinding  pre-replicative complex assembly  MCM complex  MCM complex  perinuclear region of cytoplasm  CMG complex  mitotic DNA replication initiation  
Pathways : BIOCARTACDK Regulation of DNA Replication [Genes]   
Pathways : KEGGDNA replication    Cell cycle   
REACTOMEP25205 [protein]
REACTOME PathwaysR-HSA-69052 [pathway]   
NDEx NetworkMCM3
Atlas of Cancer Signalling NetworkMCM3
Wikipedia pathwaysMCM3
Orthology - Evolution
GeneTree (enSembl)ENSG00000112118
Phylogenetic Trees/Animal Genes : TreeFamMCM3
Homologs : HomoloGeneMCM3
Homology/Alignments : Family Browser (UCSC)MCM3
Gene fusions - Rearrangements
Fusion Cancer (Beijing)SLC11A2 [12q13.12]  -  MCM3 [6p12.2]  [FUSC000333]
Fusion : QuiverMCM3
Polymorphisms : SNP and Copy number variants
NCBI Variation ViewerMCM3 [hg38]
dbSNP Single Nucleotide Polymorphism (NCBI)MCM3
Exome Variant ServerMCM3
GNOMAD BrowserENSG00000112118
Varsome BrowserMCM3
ACMGMCM3 variants
Genomic Variants (DGV)MCM3 [DGVbeta]
DECIPHERMCM3 [patients]   [syndromes]   [variants]   [genes]  
CONAN: Copy Number AnalysisMCM3 
ICGC Data PortalMCM3 
TCGA Data PortalMCM3 
Broad Tumor PortalMCM3
OASIS PortalMCM3 [ Somatic mutations - Copy number]
Somatic Mutations in Cancer : COSMICMCM3  [overview]  [genome browser]  [tissue]  [distribution]  
Somatic Mutations in Cancer : COSMIC3DMCM3
Mutations and Diseases : HGMDMCM3
intOGen PortalMCM3
LOVD (Leiden Open Variation Database)[gene] [transcripts] [variants]
DgiDB (Drug Gene Interaction Database)MCM3
DoCM (Curated mutations)MCM3
CIViC (Clinical Interpretations of Variants in Cancer)MCM3
NCG (London)MCM3
Impact of mutations[PolyPhen2] [Provean] [Buck Institute : MutDB] [Mutation Assessor] [Mutanalyser]
Genetic Testing Registry MCM3
NextProtP25205 [Medical]
Target ValidationMCM3
Huge Navigator MCM3 [HugePedia]
Clinical trials, drugs, therapy
Protein Interactions : CTDMCM3
Pharm GKB GenePA30691
Clinical trialMCM3
DataMed IndexMCM3
PubMed231 Pubmed reference(s) in Entrez
GeneRIFsGene References Into Functions (Entrez)
REVIEW articlesautomatic search in PubMed
Last year publicationsautomatic search in PubMed

Search in all EBI   NCBI

© Atlas of Genetics and Cytogenetics in Oncology and Haematology
indexed on : Fri Oct 8 21:21:55 CEST 2021

Home   Genes   Leukemias   Solid Tumors   Cancer-Prone   Deep Insight   Case Reports   Journals  Portal   Teaching   

For comments and suggestions or contributions, please contact us